Fireside Chat: Can Psychedelics Foster Human Development In The Face Of Dying? with Ira Byock, MD and Tony Bossis, PhD
At every stage in human life, personal growth is commonly engendered by a developmental crisis. If dying is seen through a developmental lens, are there opportunities for healing and growth within the processes of life completion and closure? Join palliative care physician and author, Ira Byock, and clinical psychologist and psychedelics researcher, Anthony Bossis, for a lively discussion of how skillfully guided psychedelic experiences assist people to grow through the difficult, but normal, final stage of life.
Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU Grossman School of Medicine and NYU Center for Psychedelic Medicine conducting clinical research with the psychedelic compound psilocybin. Dr. Bossis was director of palliative care research and co-principal investigator on the 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer, specifically, a rapid decrease in depression, anxiety, hopelessness, and demoralization along with improvements in spiritual well-being and quality of life. Dr. Bossis is study director and lead session guide on an FDA-approved clinical trial evaluating psilocybin-generated mystical experience with religious leaders. His primary psychedelic research interests are the treatment of end-of-life existential distress and the study of consciousness, meaning, and spirituality. He is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder of the Bellevue Hospital Palliative Care Service. He maintains a private psychotherapy practice in NYC.